518 related articles for article (PubMed ID: 28803326)
1. Short-term results of endovascular surgery with tissue plasminogen activator injection for central retinal vein occlusion.
Ishida M; Abe S; Nakagawa T; Hayashi A
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2135-2140. PubMed ID: 28803326
[TBL] [Abstract][Full Text] [Related]
2. Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons.
Bynoe LA; Hutchins RK; Lazarus HS; Friedberg MA
Retina; 2005; 25(5):625-32. PubMed ID: 16077361
[TBL] [Abstract][Full Text] [Related]
3. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
4. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
Feltgen N; Junker B; Agostini H; Hansen LL
Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
[TBL] [Abstract][Full Text] [Related]
5. Updated cannulation technique for tissue plasminogen activator injection into peripapillary retinal vein for central retinal vein occlusion.
van Overdam KA; Missotten T; Spielberg LH
Acta Ophthalmol; 2015 Dec; 93(8):739-44. PubMed ID: 26310993
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
Cekiç O; Chang S; Tseng JJ; Barile GR; Weissman H; Del Priore LV; Schiff WM; Weiss M; Klancnik JM
Retina; 2005; 25(7):846-50. PubMed ID: 16205562
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
8. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
[TBL] [Abstract][Full Text] [Related]
9. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
Retina; 2009; 29(7):932-40. PubMed ID: 19584651
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravitreal triamcinolone injection on macular edema and visual prognosis in central retinal vein occlusion.
Ozdek SC; Aydin B; Gürelik G; Bahçeci U; Hasanreisoğlu B
Int Ophthalmol; 2005; 26(1-2):27-34. PubMed ID: 16783483
[TBL] [Abstract][Full Text] [Related]
12. [Radial optic neurotomy for ischemic central retinal vein occlusion].
Lommatzsch A; Heimes B; Gutfleisch M; Spital G; Trieschmann M; Pauleikhoff D
Klin Monbl Augenheilkd; 2007 Oct; 224(10):763-9. PubMed ID: 17952819
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.
Lahey JM; Fong DS; Kearney J
Ophthalmic Surg Lasers; 1999 Jun; 30(6):427-34. PubMed ID: 10392729
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
Spaide RF; Chang LK; Klancnik JM; Yannuzzi LA; Sorenson J; Slakter JS; Freund KB; Klein R
Am J Ophthalmol; 2009 Feb; 147(2):298-306. PubMed ID: 18929354
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral niacin on central retinal vein occlusion.
Gaynon MW; Paulus YM; Rahimy E; Alexander JL; Mansour SE
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1085-1092. PubMed ID: 28161829
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.
Gokce G; Sobaci G; Durukan AH; Erdurman FC
Postgrad Med; 2013 Sep; 125(5):51-8. PubMed ID: 24113663
[TBL] [Abstract][Full Text] [Related]
17. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study.
Glacet-Bernard A; Kuhn D; Vine AK; Oubraham H; Coscas G; Soubrane G
Br J Ophthalmol; 2000 Jun; 84(6):609-13. PubMed ID: 10837386
[TBL] [Abstract][Full Text] [Related]
18. Radial optic neurotomy in central retinal vein occlusion: preliminary results.
Kaderli B; Avci R; Gelisken O
Int Ophthalmol; 2004 Jul; 25(4):215-23. PubMed ID: 16200448
[TBL] [Abstract][Full Text] [Related]
19. Comparison of surgical treatments for central retinal vein occlusion; RON vs. cannulation of tissue plasminogen activator into the retinal vein.
Yamamoto T; Kamei M; Sakaguchi H; Oshima Y; Ikuno Y; Gomi F; Ohji M; Tano Y
Retina; 2009 Sep; 29(8):1167-74. PubMed ID: 19734765
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
